Coca-Cola Amatil Stock Price Edges up after talks of Company’s Entry into Cannabis Market

Coca-Cola Amatil Limited (ASX: CCL) is in the business of manufacturing and distributing of non- alcoholic drinks, alcoholic drinks, coffee and food snacks. It is one of the largest beverage company in Asia pacific Region. According to the recent reports, Coca Cola officials are eying on the growing new segment of cannabis drinks. Coca Cola was in talks with Canadian Company Aurora Cannabis which is a licensed Cannabis producer. According to the statement released by the Coca Cola officials, Coca Cola confirmed that like many other beverage companies the Company is also having a keen interest in introducing Cannabidiol or CBD infused beverages. CBD is a type of chemical which is found in marijuana that could help in treating pain of the users but also will not get the user high. Both Coke and Aurora have shown interest in manufacturing of health focused drinks which will help the users to ease pain, inflammation and cramping. Although no decisions have been taken at this point of time. 

In the first half of 2018 Coca-Cola Amatil Limited is having Statutory earnings before interest and tax (EBIT) of $257.2 million and Statutory net profit after tax (NPAT) of 158.1 million. The Company’s underlying EBIT is 297.5m which declined 4.9 percent compared to last year and the company’s NPAT is 178.8m which declined 5.9 percent compared to last year. Company has strong performance in New Zealand and Fiji. Australian beverages witnessed some encouraging signs of revenue growth and improvement in volumes. Board of Directors declared interim dividend of 21.0 cents per share, franked to 65 percent, representing an underlying payout ratio of 85 percent for the first half of the FY 2018. Recently company had announced a strategic review of growth options for SPC. SPC is a processor of packed fruit and vegetables in Australia. The company and the Victorian Government are deciding together to invest $100mn in SPC. There are many growth opportunities in SPC like new products and market, new technology and intellectual property. The strategic review will further look on the SPC growth through change of ownership, mergers or alliances. On 18 September 2018, Coca-Cola Amatil’s stock price rose 0.524 percent after the release of this news.

CCL’s stock was trading at $9.600 with market capitalization of 6.91 bn as on 18 September 2008.

Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

Sponsored ad by Kalkine

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report


Please enter your comment!
Please enter your name here